Skip to main content

← All opportunities

DEPT OF DEFENSE › DEFENSE LOGISTICS AGENCY › TROOP SUPPORT MEDICAL › DLA TROOP SUPPORT

2027 Southern Hemisphere Influenza Vaccine

Key facts

Response deadline
Sep 30, 2026
3:00 PM UTC-04:00
Set-aside
Not stated
Notice type
Presolicitation
Posted on SAM.gov
Sep 15, 2026
Archives Oct 15, 2026

Description

The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. The formula for the 2027-2028 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate. All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 12, 2027.
Show more
This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones ([email protected]) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

From SAM.gov’s daily data file, as published on Oct 15, 2026 (UTC). SAM.gov’s latest daily file no longer lists this notice.

Contacts

Attachments

No attachment links are available here.

Record dates

Posted on SAM.gov: Sep 15, 2026
The agency’s publication date, as SAM.gov states it.
First recorded by BidLookup: Sep 20, 2026
The UTC day of the first read of SAM.gov’s listings that stored this notice.
Last confirmed: Oct 8, 2026
The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
Description as published: Oct 15, 2026 (UTC)
The date of the daily data file this text came from.

Published by the agency on SAM.gov as notice e51b168e903f43729d5c0a6654cff5ef. What these dates mean

Record

Solicitation number
SPE2DP26R0002
Search the index for this number
NAICS
325414 · Biological Product (except Diagnostic) Manufacturing
Product/service code
6505 · DRUGS AND BIOLOGICALS
Contracting office
PHILADELPHIA, PA 19111
SAM.gov notice ID
e51b168e903f43729d5c0a6654cff5ef